1. Stocks
  2. Aurinia Pharmaceuticals Inc
  3. Swot
swot-logo

Aurinia Pharmaceuticals Inc SWOT Analysis: Strengths, Weakness, Opportunity, and Threats

Aurinia Pharmaceuticals Inc has 16 Strengths, 10 Weaknesses, 2 Opportunities and 1 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential

Add SWOT widget to your site/app

High DVM Mid and Small Caps (subscription)

Expensive Stars (DVM)

Relative Outperformance versus Industry over 1 Month

Rising Net Cash Flow and Cash from Operating activity

Annual Profit Growth higher than Sector Profit Growth

High Momentum Scores (Technical Scores greater than 50)

Relative Outperformance versus Industry over 1 Week

Relative Outperformance versus Industry over 1 Month

Effectively using Shareholders fund - Return on equity (ROE) improving since last 2 year

Efficient in managing Assets to generate Profits - ROA improving since last 2 year

Company with Low Debt

Company able to generate Net Cash - Improving Net Cash Flow for last 2 years

Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years

Recent Results : Growth in Operating Profit with increase in operating margins (YoY)

Annual Net Profits improving for last 2 years

RSI indicating price strength

Negative Breakdown Second Support (LTP < S2)

PE higher than Industry PE

PEG greater than Industry PEG

High PE (PE > 40)

Stocks with Expensive Valuations according to the Trendlyne Valuation Score

Top Losers

Negative Breakdown First Support (LTP < S1)

Negative Breakdown Second Support (LTP < S2)

Top Losers

Stocks Underperforming their Industry Price Change in the Quarter

Mutual Funds Increased Shareholding over the Past Two Months

MFs increased their shareholding last quarter

Mutual Funds Decreased Shareholding in Past Month

Promoters increasing shareholding QoQ

High Piotroski Score - Companies with strong financials

Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks